332 related articles for article (PubMed ID: 33362557)
1. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
[TBL] [Abstract][Full Text] [Related]
2. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
3. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
[TBL] [Abstract][Full Text] [Related]
4. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
5. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
Nagarkatti P; Miranda K; Nagarkatti M
Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
[TBL] [Abstract][Full Text] [Related]
6. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
Kumar V
Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
[TBL] [Abstract][Full Text] [Related]
8. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
[TBL] [Abstract][Full Text] [Related]
9. Cytokine Storm in Novel Coronavirus Disease (COVID-19): Expert Management Considerations.
Mehta Y; Dixit SB; Zirpe KG; Ansari AS
Indian J Crit Care Med; 2020 Jun; 24(6):429-434. PubMed ID: 32863636
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory pathways in COVID-19: Mechanism and therapeutic interventions.
Jiang Y; Zhao T; Zhou X; Xiang Y; Gutierrez-Castrellon P; Ma X
MedComm (2020); 2022 Sep; 3(3):e154. PubMed ID: 35923762
[TBL] [Abstract][Full Text] [Related]
11. Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities.
Farshbaf A; Mohtasham N; Zare R; Mohajertehran F; Rezaee SA
J Oral Biol Craniofac Res; 2021; 11(2):132-137. PubMed ID: 33398242
[TBL] [Abstract][Full Text] [Related]
12. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
13. Commentary: Phosphodiesterase 4 inhibitors as potential adjunct treatment targeting the cytokine storm in COVID-19.
Dalamaga M; Karampela I; Mantzoros CS
Metabolism; 2020 Aug; 109():154282. PubMed ID: 32497535
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic Nanoparticles Potentiate the Anti-Inflammatory Properties of Dexamethasone and Reduce the Cytokine Storm Syndrome: An Additional Weapon against COVID-19?
Molinaro R; Pasto A; Taraballi F; Giordano F; Azzi JA; Tasciotti E; Corbo C
Nanomaterials (Basel); 2020 Nov; 10(11):. PubMed ID: 33233748
[TBL] [Abstract][Full Text] [Related]
15. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.
Peter AE; Sandeep BV; Rao BG; Kalpana VL
Front Pharmacol; 2020; 11():583777. PubMed ID: 33708109
[TBL] [Abstract][Full Text] [Related]
16. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
17. Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin.
Alunno A; Carubbi F; Rodríguez-Carrio J
RMD Open; 2020 May; 6(1):. PubMed ID: 32423970
[TBL] [Abstract][Full Text] [Related]
18. Gene expression profiling of corona virus microarray datasets to identify crucial targets in COVID-19 patients.
Ramesh P; Veerappapillai S; Karuppasamy R
Gene Rep; 2021 Mar; 22():100980. PubMed ID: 33263093
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms responsible for acute coronary events in COVID-19.
Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
